United States Antithrombin Market Report 2017

November 2017 | 100 pages | ID: UA4468A389BWEN
QYResearch

Abstracts

In this report, the United States Antithrombin market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Antithrombin in these regions, from 2012 to 2022 (forecast).

United States Antithrombin market competition by top manufacturers/players, with Antithrombin sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• rEVO Biologics
• Grifols
• Shire
• CSL Limited
• Kedrion
• Lee Bisolutions
• Scripps Laboratories
• Octapharma
• Dem ilac
• Diapharma Group

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Lyophilized
• Liquid

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Therapeutics
• Research
• Diagnostics

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Antithrombin Market Report 2017

1 ANTITHROMBIN OVERVIEW

1.1 Product Overview and Scope of Antithrombin
1.2 Classification of Antithrombin by Product Category
  1.2.1 United States Antithrombin Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Antithrombin Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Lyophilized
  1.2.4 Liquid
1.3 United States Antithrombin Market by Application/End Users
  1.3.1 United States Antithrombin Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Therapeutics
  1.3.3 Research
  1.3.4 Diagnostics
1.4 United States Antithrombin Market by Region
  1.4.1 United States Antithrombin Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Antithrombin Status and Prospect (2012-2022)
  1.4.3 Southwest Antithrombin Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Antithrombin Status and Prospect (2012-2022)
  1.4.5 New England Antithrombin Status and Prospect (2012-2022)
  1.4.6 The South Antithrombin Status and Prospect (2012-2022)
  1.4.7 The Midwest Antithrombin Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Antithrombin (2012-2022)
  1.5.1 United States Antithrombin Sales and Growth Rate (2012-2022)
  1.5.2 United States Antithrombin Revenue and Growth Rate (2012-2022)

2 UNITED STATES ANTITHROMBIN MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Antithrombin Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Antithrombin Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Antithrombin Average Price by Players/Suppliers (2012-2017)
2.4 United States Antithrombin Market Competitive Situation and Trends
  2.4.1 United States Antithrombin Market Concentration Rate
  2.4.2 United States Antithrombin Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Antithrombin Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES ANTITHROMBIN SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Antithrombin Sales and Market Share by Region (2012-2017)
3.2 United States Antithrombin Revenue and Market Share by Region (2012-2017)
3.3 United States Antithrombin Price by Region (2012-2017)

4 UNITED STATES ANTITHROMBIN SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Antithrombin Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Antithrombin Revenue and Market Share by Type (2012-2017)
4.3 United States Antithrombin Price by Type (2012-2017)
4.4 United States Antithrombin Sales Growth Rate by Type (2012-2017)

5 UNITED STATES ANTITHROMBIN SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Antithrombin Sales and Market Share by Application (2012-2017)
5.2 United States Antithrombin Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES ANTITHROMBIN PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 rEVO Biologics
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Antithrombin Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 rEVO Biologics Antithrombin Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Grifols
  6.2.2 Antithrombin Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Grifols Antithrombin Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Shire
  6.3.2 Antithrombin Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Shire Antithrombin Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 CSL Limited
  6.4.2 Antithrombin Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 CSL Limited Antithrombin Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Kedrion
  6.5.2 Antithrombin Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Kedrion Antithrombin Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Lee Bisolutions
  6.6.2 Antithrombin Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Lee Bisolutions Antithrombin Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Scripps Laboratories
  6.7.2 Antithrombin Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Scripps Laboratories Antithrombin Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Octapharma
  6.8.2 Antithrombin Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Octapharma Antithrombin Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Dem ilac
  6.9.2 Antithrombin Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Dem ilac Antithrombin Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Diapharma Group
  6.10.2 Antithrombin Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Diapharma Group Antithrombin Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview

7 ANTITHROMBIN MANUFACTURING COST ANALYSIS

7.1 Antithrombin Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Antithrombin

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Antithrombin Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Antithrombin Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES ANTITHROMBIN MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Antithrombin Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Antithrombin Sales Volume Forecast by Type (2017-2022)
11.3 United States Antithrombin Sales Volume Forecast by Application (2017-2022)
11.4 United States Antithrombin Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Antithrombin
Figure United States Antithrombin Market Size (K Units) by Type (2012-2022)
Figure United States Antithrombin Sales Volume Market Share by Type (Product Category) in 2016
Figure Lyophilized Product Picture
Figure Liquid Product Picture
Figure United States Antithrombin Market Size (K Units) by Application (2012-2022)
Figure United States Sales Market Share of Antithrombin by Application in 2016
Figure Therapeutics Examples
Table Key Downstream Customer in Therapeutics
Figure Research Examples
Table Key Downstream Customer in Research
Figure Diagnostics Examples
Table Key Downstream Customer in Diagnostics
Figure United States Antithrombin Market Size (Million USD) by Region (2012-2022)
Figure The West Antithrombin Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Antithrombin Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Antithrombin Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Antithrombin Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Antithrombin Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Antithrombin Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Antithrombin Sales (K Units) and Growth Rate (2012-2022)
Figure United States Antithrombin Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Antithrombin Market Major Players Product Sales Volume (K Units) (2012-2017)
Table United States Antithrombin Sales (K Units) of Key Players/Suppliers (2012-2017)
Table United States Antithrombin Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Antithrombin Sales Share by Players/Suppliers
Figure 2017 United States Antithrombin Sales Share by Players/Suppliers
Figure United States Antithrombin Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Antithrombin Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Antithrombin Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Antithrombin Revenue Share by Players/Suppliers
Figure 2017 United States Antithrombin Revenue Share by Players/Suppliers
Table United States Market Antithrombin Average Price (USD/Unit) of Key Players/Suppliers (2012-2017)
Figure United States Market Antithrombin Average Price (USD/Unit) of Key Players/Suppliers in 2016
Figure United States Antithrombin Market Share of Top 3 Players/Suppliers
Figure United States Antithrombin Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Antithrombin Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Antithrombin Product Category
Table United States Antithrombin Sales (K Units) by Region (2012-2017)
Table United States Antithrombin Sales Share by Region (2012-2017)
Figure United States Antithrombin Sales Share by Region (2012-2017)
Figure United States Antithrombin Sales Market Share by Region in 2016
Table United States Antithrombin Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Antithrombin Revenue Share by Region (2012-2017)
Figure United States Antithrombin Revenue Market Share by Region (2012-2017)
Figure United States Antithrombin Revenue Market Share by Region in 2016
Table United States Antithrombin Price (USD/Unit) by Region (2012-2017)
Table United States Antithrombin Sales (K Units) by Type (2012-2017)
Table United States Antithrombin Sales Share by Type (2012-2017)
Figure United States Antithrombin Sales Share by Type (2012-2017)
Figure United States Antithrombin Sales Market Share by Type in 2016
Table United States Antithrombin Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Antithrombin Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Antithrombin by Type (2012-2017)
Figure Revenue Market Share of Antithrombin by Type in 2016
Table United States Antithrombin Price (USD/Unit) by Types (2012-2017)
Figure United States Antithrombin Sales Growth Rate by Type (2012-2017)
Table United States Antithrombin Sales (K Units) by Application (2012-2017)
Table United States Antithrombin Sales Market Share by Application (2012-2017)
Figure United States Antithrombin Sales Market Share by Application (2012-2017)
Figure United States Antithrombin Sales Market Share by Application in 2016
Table United States Antithrombin Sales Growth Rate by Application (2012-2017)
Figure United States Antithrombin Sales Growth Rate by Application (2012-2017)
Table rEVO Biologics Basic Information List
Table rEVO Biologics Antithrombin Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure rEVO Biologics Antithrombin Sales Growth Rate (2012-2017)
Figure rEVO Biologics Antithrombin Sales Market Share in United States (2012-2017)
Figure rEVO Biologics Antithrombin Revenue Market Share in United States (2012-2017)
Table Grifols Basic Information List
Table Grifols Antithrombin Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Grifols Antithrombin Sales Growth Rate (2012-2017)
Figure Grifols Antithrombin Sales Market Share in United States (2012-2017)
Figure Grifols Antithrombin Revenue Market Share in United States (2012-2017)
Table Shire Basic Information List
Table Shire Antithrombin Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Shire Antithrombin Sales Growth Rate (2012-2017)
Figure Shire Antithrombin Sales Market Share in United States (2012-2017)
Figure Shire Antithrombin Revenue Market Share in United States (2012-2017)
Table CSL Limited Basic Information List
Table CSL Limited Antithrombin Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure CSL Limited Antithrombin Sales Growth Rate (2012-2017)
Figure CSL Limited Antithrombin Sales Market Share in United States (2012-2017)
Figure CSL Limited Antithrombin Revenue Market Share in United States (2012-2017)
Table Kedrion Basic Information List
Table Kedrion Antithrombin Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Kedrion Antithrombin Sales Growth Rate (2012-2017)
Figure Kedrion Antithrombin Sales Market Share in United States (2012-2017)
Figure Kedrion Antithrombin Revenue Market Share in United States (2012-2017)
Table Lee Bisolutions Basic Information List
Table Lee Bisolutions Antithrombin Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Lee Bisolutions Antithrombin Sales Growth Rate (2012-2017)
Figure Lee Bisolutions Antithrombin Sales Market Share in United States (2012-2017)
Figure Lee Bisolutions Antithrombin Revenue Market Share in United States (2012-2017)
Table Scripps Laboratories Basic Information List
Table Scripps Laboratories Antithrombin Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Scripps Laboratories Antithrombin Sales Growth Rate (2012-2017)
Figure Scripps Laboratories Antithrombin Sales Market Share in United States (2012-2017)
Figure Scripps Laboratories Antithrombin Revenue Market Share in United States (2012-2017)
Table Octapharma Basic Information List
Table Octapharma Antithrombin Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Octapharma Antithrombin Sales Growth Rate (2012-2017)
Figure Octapharma Antithrombin Sales Market Share in United States (2012-2017)
Figure Octapharma Antithrombin Revenue Market Share in United States (2012-2017)
Table Dem ilac Basic Information List
Table Dem ilac Antithrombin Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Dem ilac Antithrombin Sales Growth Rate (2012-2017)
Figure Dem ilac Antithrombin Sales Market Share in United States (2012-2017)
Figure Dem ilac Antithrombin Revenue Market Share in United States (2012-2017)
Table Diapharma Group Basic Information List
Table Diapharma Group Antithrombin Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Diapharma Group Antithrombin Sales Growth Rate (2012-2017)
Figure Diapharma Group Antithrombin Sales Market Share in United States (2012-2017)
Figure Diapharma Group Antithrombin Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Antithrombin
Figure Manufacturing Process Analysis of Antithrombin
Figure Antithrombin Industrial Chain Analysis
Table Raw Materials Sources of Antithrombin Major Players/Suppliers in 2016
Table Major Buyers of Antithrombin
Table Distributors/Traders List
Figure United States Antithrombin Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure United States Antithrombin Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Antithrombin Price (USD/Unit) Trend Forecast (2017-2022)
Table United States Antithrombin Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Antithrombin Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Antithrombin Sales Volume (K Units) Forecast by Type in 2022
Table United States Antithrombin Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Antithrombin Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Antithrombin Sales Volume (K Units) Forecast by Application in 2022
Table United States Antithrombin Sales Volume (K Units) Forecast by Region (2017-2022)
Table United States Antithrombin Sales Volume Share Forecast by Region (2017-2022)
Figure United States Antithrombin Sales Volume Share Forecast by Region (2017-2022)
Figure United States Antithrombin Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources